These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32947603)

  • 1. Bifidobacterium breve BBG-001 and intestinal barrier function in preterm babies: Exploratory Studies from the PiPS Trial.
    Fleming P; Wilks M; Eaton S; Panton N; Hutchinson R; Akyempon A; Hardy P; Millar MR; Costeloe K
    Pediatr Res; 2021 May; 89(7):1818-1824. PubMed ID: 32947603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial.
    Costeloe K; Bowler U; Brocklehurst P; Hardy P; Heal P; Juszczak E; King A; Panton N; Stacey F; Whiley A; Wilks M; Millar MR
    Health Technol Assess; 2016 Aug; 20(66):1-194. PubMed ID: 27594381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial.
    Costeloe K; Hardy P; Juszczak E; Wilks M; Millar MR;
    Lancet; 2016 Feb; 387(10019):649-660. PubMed ID: 26628328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial microbes for premature infants, and children with malignancy undergoing chemotherapy.
    Yamashiro Y; Nagata S
    Benef Microbes; 2010 Nov; 1(4):357-65. PubMed ID: 21831775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and evaluation of probiotic potential of Bifidobacterium breve AHC3 isolated from chicken intestines and its effect on necrotizing enterocolitis (NEC) in newborn SD rats.
    Lin X; Wu C
    PLoS One; 2023; 18(11):e0287799. PubMed ID: 37917716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Science behind Bifidobacterium breve M-16V in Infant Health.
    Wong CB; Iwabuchi N; Xiao JZ
    Nutrients; 2019 Jul; 11(8):. PubMed ID: 31349739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Microbiome of Infants Recruited to a Randomised Placebo-controlled Probiotic Trial (PiPS Trial).
    Millar M; Seale J; Greenland M; Hardy P; Juszczak E; Wilks M; Panton N; Costeloe K; Wade WG
    EBioMedicine; 2017 Jun; 20():255-262. PubMed ID: 28571671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.
    Patole S; Keil AD; Chang A; Nathan E; Doherty D; Simmer K; Esvaran M; Conway P
    PLoS One; 2014; 9(3):e89511. PubMed ID: 24594833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial.
    Braga TD; da Silva GA; de Lira PI; de Carvalho Lima M
    Am J Clin Nutr; 2011 Jan; 93(1):81-6. PubMed ID: 20980486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Bacteriologic Characteristics of Six Cases of Bifidobacterium breve Bacteremia Due to Probiotic Administration in the Neonatal Intensive Care Unit.
    Sakurai Y; Watanabe T; Miura Y; Uchida T; Suda N; Yoshida M; Nawa T
    Pediatr Infect Dis J; 2022 Jan; 41(1):62-65. PubMed ID: 34889871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Bifidobacterium breve (BBG-01) in preterm infants.
    Kitajima H; Hirano S
    Pediatr Int; 2017 Mar; 59(3):328-333. PubMed ID: 27538261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifidobacterium breve M-16V as a Probiotic for Preterm Infants: A Strain-Specific Systematic Review.
    Athalye-Jape G; Rao S; Simmer K; Patole S
    JPEN J Parenter Enteral Nutr; 2018 May; 42(4):677-688. PubMed ID: 28796951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Taro (Colocasia esculenta) Water-Soluble Non-Starch Polysaccharide, Lactobacillus acidophilus, Bifidobacterium breve, Bifidobacterium infantis, and Their Synbiotic Mixtures on Pro-Inflammatory Cytokine Interleukin-8 Production.
    Anwar M; Mros S; McConnell M; Bekhit AEA
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of different probiotic combinations on death and necrotizing enterocolitis in a premature rat model.
    Wu SF; Chiu HY; Chen AC; Lin HY; Lin HC; Caplan M
    J Pediatr Gastroenterol Nutr; 2013 Jul; 57(1):23-8. PubMed ID: 23535766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in preterm small versus appropriate for gestation infants after
    Athalye-Jape G; Minaee N; Nathan E; Simmer K; Patole S
    J Matern Fetal Neonatal Med; 2020 Jul; 33(13):2209-2215. PubMed ID: 30394171
    [No Abstract]   [Full Text] [Related]  

  • 16. Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat model.
    Satoh T; Izumi H; Iwabuchi N; Odamaki T; Namba K; Abe F; Xiao JZ
    Benef Microbes; 2016 Feb; 7(1):75-82. PubMed ID: 26420070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Bifidobacterium breve M-16V supplementation on faecal bifidobacteria in growth restricted very preterm infants - analysis from a randomised trial.
    Patole SK; Keil AD; Nathan E; Doherty D; Esvaran M; Simmer KN; Conway P
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3751-5. PubMed ID: 26821074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics for prevention of necrotizing enterocolitis in preterm infants.
    AlFaleh K; Anabrees J
    Evid Based Child Health; 2014 Sep; 9(3):584-671. PubMed ID: 25236307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Historical aspects of probiotic use to prevent necrotising enterocolitis in preterm babies.
    Jarrett P; Meczner A; Costeloe K; Fleming P
    Early Hum Dev; 2019 Aug; 135():51-57. PubMed ID: 31153726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly Specialized Carbohydrate Metabolism Capability in
    Ma B; Sundararajan S; Nadimpalli G; France M; McComb E; Rutt L; Lemme-Dumit JM; Janofsky E; Roskes LS; Gajer P; Fu L; Yang H; Humphrys M; Tallon LJ; Sadzewicz L; Pasetti MF; Ravel J; Viscardi RM
    mBio; 2022 Jun; 13(3):e0129922. PubMed ID: 35695455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.